Skip to main content
. 2020 Jun 24;9(6):1982. doi: 10.3390/jcm9061982

Table 2.

Characteristics of treatment.

Dose Interval N = 101 Combined Treatment N = 101
2 weeks 50 (49.50%) Cyclosporine 9 (8.91%)
3 weeks 5 (4.95%) Methotrexate 7 (6.93%)
4 weeks 29 (28.71%) Systemic steroid 5 (4.95%)
Increase of interval 16 (15.84%) None (dupilumab-only) 80 (79.21%)
Decrease of interval 1 (0.99%)